High male chimerism in the female breast shows quantitative links with cancer

International Journal of Cancer

Volumn 133, Issue 4, 2013, Pages 835-842

  Dhimolea, Eugen ^a   Denes, Viktoria ^b   Lakk, Monika ^b   Al Bazzaz, Sana ^c   Aziz Zaman, Sonya ^d   Pilichowska, Monika ^e   Geck, Peter ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PÉCS   (Hungary)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

allogeneic stem cells; breast cancer; fetal chimerism; HER2; pregnancy protection; Y chromosome

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GENOMIC DNA; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PATIENT; CELL INTERACTION; CELL LINEAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETAL STEM CELL; FETUS; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; Y CHROMOSOME;

BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CHIMERISM; CHROMOSOMES, HUMAN, Y; DNA; DNA PRIMERS; FEMALE; GENES, ERBB-2; HUMANS; MALE; POLYMERASE CHAIN REACTION;

EID: 84878830019     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28077     Document Type: Article

References (49)

1. Ratajczak MZ, Shin DM, Kucia M,. Very small embryonic/epiblast-like stem cells: a missing link to support the germ line hypothesis of cancer development? Am J Pathol 2009; 174: 1985-92.
2. Karoubi G, Cortes-Dericks L, Gugger M, et al. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma. J Surg Oncol 2010; 102: 689-98.
3. Rothenberg ME, Clarke MF, Diehn M,. The myc connection: ES cells and cancer. Cell 2010; 143: 184-6.
4. Geck P, Maffini MV, Szelei J, et al. Androgen-induced proliferative quiescence in prostate cancer cells: The role of AS3 as its mediator. Proc Natl Acad Sci USA 2000; 97: 10185-90.
5. Geck P, Sonnenschein C, Soto AM,. The D13S171 marker, misannotated to BRCA2, links the AS3 gene to various cancers. Am J Hum Genet 2001; 69: 461-3. (Pubitemid 32695219)
6. Denes V, Pilichowska M, Makarovskiy A, et al. Loss of a cohesin-linked suppressor APRIN (Pds5b) disrupts stem cell programs in embryonal carcinoma: an emerging cohesin role in tumor suppression. Oncogene 2010; 29: 3446-52.
7. Zhang B, Jain S, Song H, et al. Mice lacking sister chromatid cohesion protein PDS5B exhibit developmental abnormalities reminiscent of cornelia de lange syndrome. Development 2007; 134: 3191-201. (Pubitemid 47506157)
8. Kunnev D, Ivanov I, Ionov Y,. Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells. BMC Cancer 2009; 9: 318.
9. Zhang Y, Huang X, Qi J, et al. Correlation of genomic and expression alterations of AS3 with esophageal squamous cell carcinoma. J Genet Genomics 2008; 35: 267-71. (Pubitemid 351680790)
10. Blum B, Benvenisty N,. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008; 100: 133-58. (Pubitemid 351932182)
11. Bianchi DW,., Robert E,. Gross lecture. Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with stem cell therapy. J Pediatr Surg 2007; 42: 12-18. (Pubitemid 46043356)
12. Lee ES, Bou-Gharios G, Seppanen E, et al. Fetal stem cell microchimerism: Natural-born healers or killers? Mol Hum Reprod 2010; 16: 869-78.
13. Fujiki Y, Johnson KL, Peter I, et al. Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers. Biol Reprod 2009; 81: 26-32.
14. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93: 705-8. (Pubitemid 26041153)
15. Khosrotehrani K, Bianchi DW,. Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse. J Cell Sci 2005; 118: 1559-63. (Pubitemid 40691884)
16. Klonisch T, Drouin R,. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends Mol Med 2009; 15: 510-18.
17. Lo YM, Patel P, Baigent CN, et al. Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction. Hum Genet 1993; 90: 483-8. (Pubitemid 23072834)
18. Arnemann J, Jakubiczka S, Thuring S, et al. Cloning and sequence analysis of a human Y-chromosome-derived, testicular cDNA, TSPY. Genomics 1991; 11: 108-14.
19. Russo J, Moral R, Balogh GA, et al. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005; 7: 131-42. (Pubitemid 40704134)
20. Weinstein M, Gorrindo T, Riley A, et al. Timing of menopause and patterns of menstrual bleeding. Am J Epidemiol 2003; 158: 782-91. (Pubitemid 37237242)
21. Bustin SA, Beaulieu JF, Huggett J, et al. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol 2010; 11: 74.
22. Legrand B, Mazancourt P, Durigon M, et al. DNA genotyping of unbuffered formalin fixed paraffin embedded tissues. Forensic Sci Int 2002; 125: 205-11. (Pubitemid 34224146)
23. Lambert NC, Lo YM, Erickson TD, et al. Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer. Blood 2002; 100: 2845-51.
24. An SF, Fleming KA,. Removal of inhibitor(s) of the polymerase chain reaction from formalin fixed, paraffin wax embedded tissues. J Clin Pathol 1991; 44: 924-7.
25. Bellott DW, Page DC,. Reconstructing the evolution of vertebrate sex chromosomes. Cold Spring Harb Symp Quant Biol 2009; 74: 345-353.
26. Chamberlain JS, Gibbs RA, Ranier JE, et al. Deletion screening of the duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 1988; 16: 11141-56. (Pubitemid 19008461)
27. Schnitt SJ,. Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy. Mod Pathol 2010; 23(Suppl 2): S60-4.
28. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007; 1: 555-67. (Pubitemid 350056407)
29. Eirew P, Stingl J, Raouf A, et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 2008; 14: 1384-9.
30. Stingl J, Eirew P, Ricketson I, et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-7. (Pubitemid 43292419)
31. O'Donoghue K, Chan J, de la Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004; 364: 179-82. (Pubitemid 38891690)
32. Gammill HS, Nelson JL,. Naturally acquired microchimerism. Int J Dev Biol 2010; 54: 531-43.
33. Carter AM, Pijnenborg R,. Evolution of invasive placentation with special reference to non-human primates. Best Pract Res Clin Obstet Gynaecol 2011; 25: 249-57.
34. Polyak K, Kalluri R,. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2010; 2: a003244.
35. Bian ZY, Fan QM, Li G, et al. Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and saos-2. Cancer Sci 2010; 101: 2554-60.
36. Fang S, Salven P,. Stem cells in tumor angiogenesis. J Mol Cell Cardiol 2011; 50: 290-5.
37. Russo J, Russo IH,. Development of the human breast. Maturitas 2004; 49: 2-15. (Pubitemid 39209366)
38. Gadi VK, Nelson JL,. Fetal microchimerism in women with breast cancer. Cancer Res 2007; 67: 9035-8. (Pubitemid 47535887)
39. Gadi VK, Malone KE, Guthrie KA, et al. Case-control study of fetal microchimerism and breast cancer. PLoS One 2008; 3: e1706.
40. Gadi VK,. Fetal microchimerism in breast from women with and without breast cancer. Breast Cancer Res Treat 2010; 121: 241-4.
41. Cha D, Khosrotehrani K, Kim Y, et al. Cervical cancer and microchimerism. Obstet Gynecol 2003; 102: 774-81. (Pubitemid 37206414)
42. Cirello V, Recalcati MP, Muzza M, et al. Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res 2008; 68: 8482-8.
43. Dubernard G, Aractingi S, Oster M, et al. Breast cancer stroma frequently recruits fetal derived cells during pregnancy. Breast Cancer Res 2008; 10: R14.
44. Ariga H, Ohto H, Busch MP, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41: 1524-30. (Pubitemid 34072677)
45. Fujiki Y, Johnson KL, Tighiouart H, et al. Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung. Biol Reprod 2008; 79: 841-8.
46. O'Donoghue K, Chan J, de la Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004; 364: 179-82. (Pubitemid 38891690)
47. Russo J, Balogh GA, Heulings R, et al. Molecular basis of pregnancy-induced breast cancer protection. Eur J Cancer Prev 2006; 15: 306-42. (Pubitemid 44060488)
48. Eheman CR, Shaw KM, Ryerson AB, et al. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United states, 1999-2004. Cancer Epidemiol Biomarkers Prev 2009; 18: 1763-9.
49. Menard S, Fortis S, Castiglioni F, et al. HER2 as a prognostic factor in breast cancer. Oncology 2001; 61 (Suppl 2): 67-72. (Pubitemid 33033427)